Neptune Technologies & Bioressources Stock Price, News & Analysis (NASDAQ:NEPT)

$3.01 -0.03 (-0.99 %)
(As of 02/20/2018 10:37 AM ET)
Previous Close$3.01
Today's Range$2.94 - $3.12
52-Week Range$0.70 - $3.59
Volume624,800 shs
Average Volume1.06 million shs
Market Capitalization$237.20 million
P/E Ratio37.63
Dividend YieldN/A
Beta1.19

About Neptune Technologies & Bioressources (NASDAQ:NEPT)

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti. The Company's NKO is a marine oil extracted from krill (Euphasia superba). NKO consists of phospholipids, which contain omega-3 fatty acids, including eicosapentaenoic acid and docosahexaenoic acid (EPA & DHA), and antioxidants, such as astaxanthin, vitamin A and vitamin E. The Company sells OCEANO3 directly to consumers in Canada through its online platform (www.oceano3.com), under its brand name.

Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio37.63
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$17.36 million
Price / Sales13.66
Cash FlowN/A
Price / CashN/A
Book Value$0.66 per share
Price / Book4.56

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares78,800,000

Neptune Technologies & Bioressources (NASDAQ:NEPT) Frequently Asked Questions

What is Neptune Technologies & Bioressources' stock symbol?

Neptune Technologies & Bioressources trades on the NASDAQ under the ticker symbol "NEPT."

How were Neptune Technologies & Bioressources' earnings last quarter?

Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) issued its quarterly earnings data on Wednesday, October, 12th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $8.91 million for the quarter. View Neptune Technologies & Bioressources' Earnings History.

Who are some of Neptune Technologies & Bioressources' key competitors?

Who are Neptune Technologies & Bioressources' key executives?

Neptune Technologies & Bioressources' management team includes the folowing people:

  • John Moretz, Chairman of the Board
  • James Stuart Hamilton, President, Chief Executive Officer, Director
  • Mario Paradis, Chief Financial Officer
  • Michel Timperio, Senior Vice President of Sales - Global Sales
  • Pierre Lemieux Ph.D., Chief Operating Officer of Acasti
  • Jean-Daniel Belanger, Corporate Secretary and Director - Corporate Affairs
  • Harlan W. Waksal M.D., Director (Age 61)
  • Valier Boivin, Independent Director
  • Ronald Denis, Independent Director
  • Adrian Taylor Montgomery, Independent Director

Who owns Neptune Technologies & Bioressources stock?

Neptune Technologies & Bioressources' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Perceptive Advisors LLC (10.65%), PERCEPTIVE ADVISORS LLC (10.20%), PERCEPTIVE ADVISORS LLC (10.20%), Deutsche Bank AG (0.24%) and Virtu Financial LLC (0.22%). View Institutional Ownership Trends for Neptune Technologies & Bioressources.

Who bought Neptune Technologies & Bioressources stock? Who is buying Neptune Technologies & Bioressources stock?

Neptune Technologies & Bioressources' stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Deutsche Bank AG and Virtu Financial LLC. View Insider Buying and Selling for Neptune Technologies & Bioressources.

How do I buy Neptune Technologies & Bioressources stock?

Shares of Neptune Technologies & Bioressources can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neptune Technologies & Bioressources' stock price today?

One share of Neptune Technologies & Bioressources stock can currently be purchased for approximately $3.01.

How big of a company is Neptune Technologies & Bioressources?

Neptune Technologies & Bioressources has a market capitalization of $237.20 million and generates $17.36 million in revenue each year. The biotechnology company earns $-5,730,000.00 in net income (profit) each year or $0.08 on an earnings per share basis.

How can I contact Neptune Technologies & Bioressources?

Neptune Technologies & Bioressources' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]


MarketBeat Community Rating for Neptune Technologies & Bioressources (NEPT)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about Neptune Technologies & Bioressources and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Neptune Technologies & Bioressources (NASDAQ:NEPT) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Neptune Technologies & Bioressources (NASDAQ:NEPT) Earnings History and Estimates Chart

Earnings by Quarter for Neptune Technologies & Bioressources (NASDAQ:NEPT)

Neptune Technologies & Bioressources (NASDAQ NEPT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/12/2017Q316$0.02$0.11$12.30 millionViewN/AView Earnings Details
10/12/2016Q2 2017($0.02)$8.91 millionViewN/AView Earnings Details
7/11/2016Q1 2017($0.02)$8.66 millionViewN/AView Earnings Details
5/25/2016Q4 2016$0.01$7.20 millionViewN/AView Earnings Details
1/12/2016Q3 2016($0.02)$4.18 millionViewN/AView Earnings Details
10/14/2015Q2 2016($0.02)$3.43 millionViewN/AView Earnings Details
7/13/2015Q1 2016($0.05)$2.18 millionViewN/AView Earnings Details
5/27/2015Q4 2015($0.10)$3.25 millionViewN/AView Earnings Details
1/13/2015Q413($0.14)($0.05)$5.06 million$3.98 millionViewN/AView Earnings Details
10/14/2014Q2 2015($0.11)($0.15)$4.19 million$2.34 millionViewN/AView Earnings Details
7/15/2014Q1 2015($0.08)($0.06)$6.71 million$3.44 millionViewN/AView Earnings Details
5/21/2014Q4 2014($0.08)($0.07)$5.84 million$3.37 millionViewN/AView Earnings Details
1/14/2014Nov 2013($0.09)$4.03 millionViewN/AView Earnings Details
10/15/2013Q2 2014($0.06)$5.16 millionViewN/AView Earnings Details
7/15/2013Q1 2014($0.07)$5.86 millionViewN/AView Earnings Details
5/22/2013Q4 2013($0.01)$4.45 millionViewN/AView Earnings Details
1/15/2013Q313($0.18)$5.12 million$6.60 millionViewN/AView Earnings Details
10/15/2012Q2 2013$0.01($0.08)ViewN/AView Earnings Details
7/16/2012Q1 2013($0.02)ViewN/AView Earnings Details
5/25/2012Q4 2012($0.02)($0.01)ViewN/AView Earnings Details
1/17/2012Q3 2012($0.03)($0.01)ViewN/AView Earnings Details
10/14/2011Q2 2012($0.03)($0.04)ViewN/AView Earnings Details
8/16/2011Q1 2012($0.01)($0.03)ViewN/AView Earnings Details
5/31/2011Q4 2011$0.02$0.05ViewN/AView Earnings Details
1/13/2011Q3 2011$0.03$0.04ViewN/AView Earnings Details
10/15/2010Q2 2011$0.01ViewN/AView Earnings Details
7/14/2010Q1 2011$0.01ViewN/AView Earnings Details
10/15/2009Q2 2010($0.04)($0.04)ViewN/AView Earnings Details
7/15/2009Q1 2010($0.04)ViewN/AView Earnings Details
1/14/2009Q3 2009($0.04)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Neptune Technologies & Bioressources (NASDAQ:NEPT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Neptune Technologies & Bioressources (NASDAQ:NEPT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neptune Technologies & Bioressources (NASDAQ NEPT)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Neptune Technologies & Bioressources (NASDAQ NEPT) News Headlines

Source:
DateHeadline
Neptune Technologies & Bioressources (NEPT) Set to Announce Earnings on WednesdayNeptune Technologies & Bioressources (NEPT) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - February 7 at 4:38 AM
Wired News – Neptune Signs Exclusive Research Agreement for Developing New Medical and Wellness Cannabinoid-Based ProductsWired News – Neptune Signs Exclusive Research Agreement for Developing New Medical and Wellness Cannabinoid-Based Products
finance.yahoo.com - January 22 at 6:02 PM
Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q2, 2018 By the Numbers : November 30, 2017Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q2, 2018 By the Numbers : November 30, 2017
finance.yahoo.com - November 30 at 5:30 PM
Neptune Technologies & Bioresources Inc (NEPT) Short Interest Down 81.2% in SeptemberNeptune Technologies & Bioresources Inc (NEPT) Short Interest Down 81.2% in September
www.americanbankingnews.com - October 14 at 1:40 AM
Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017
finance.yahoo.com - September 14 at 8:15 AM
Neptune Technologies & Bioresources, Inc.: Price momentum supported by strong fundamentalsNeptune Technologies & Bioresources, Inc.: Price momentum supported by strong fundamentals
finance.yahoo.com - August 19 at 5:15 AM
Neptune Announces the Election of its DirectorsNeptune Announces the Election of its Directors
finance.yahoo.com - August 17 at 3:56 PM
Neptune Technologies & Bioresources Inc 2018 Q1 - Results - Earnings Call SlidesNeptune Technologies & Bioresources Inc 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - August 17 at 6:10 AM
Acasti Pharma Reports First Quarter FY 2018 Financial ResultsAcasti Pharma Reports First Quarter FY 2018 Financial Results
finance.yahoo.com - August 15 at 2:57 AM
Aker BioMarine and Neptune Announce Closing of $US34 Million Transaction to Accelerate Business and Industry DevelopmentAker BioMarine and Neptune Announce Closing of $US34 Million Transaction to Accelerate Business and Industry Development
finance.yahoo.com - August 9 at 3:04 AM
Neptune to Hold Conference Call to Discuss the Transaction with Aker BioMarineNeptune to Hold Conference Call to Discuss the Transaction with Aker BioMarine
finance.yahoo.com - August 9 at 3:04 AM
Neptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz as ChairmanNeptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz as Chairman
finance.yahoo.com - August 9 at 3:04 AM
Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) to Release Earnings on MondayNeptune Technologies & Bioresources Inc (NASDAQ:NEPT) to Release Earnings on Monday
www.americanbankingnews.com - August 7 at 7:46 AM
Neptune Receives Nasdaq Notification Regarding Minimum Bid RequirementsNeptune Receives Nasdaq Notification Regarding Minimum Bid Requirements
finance.yahoo.com - July 28 at 6:09 AM
Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017
finance.yahoo.com - July 26 at 4:19 AM
Featured Company News - Opexa Therapeutics and Acer Therapeutics Announced Merger Agreement Followed by Concurrent Financing from Acer Investor SyndicateFeatured Company News - Opexa Therapeutics and Acer Therapeutics Announced Merger Agreement Followed by Concurrent Financing from Acer Investor Syndicate
finance.yahoo.com - July 5 at 8:53 AM
Neptune Technologies & Bioresources Inc 2017 Q3 - Results - Earnings Call SlidesNeptune Technologies & Bioresources Inc 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - January 14 at 1:12 AM
Neptune Announces Record Third Quarter ResultsNeptune Announces Record Third Quarter Results
us.rd.yahoo.com - January 12 at 7:23 PM
Acasti Pharma Reports Third Quarter 2017 Financial ResultsAcasti Pharma Reports Third Quarter 2017 Financial Results
us.rd.yahoo.com - January 12 at 7:23 PM

SEC Filings

Neptune Technologies & Bioressources (NASDAQ:NEPT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Neptune Technologies & Bioressources (NASDAQ:NEPT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Neptune Technologies & Bioressources (NASDAQ NEPT) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.